Company Monitoring Page for Novartis

latest headlines for company on cafepharma

What’s to Be Expected from Novartis’s 3Q16 Earnings?
Market Realist
Fri, 10/21/16 - 10:20 pm
Tags:
Novartis, earnings
Novartis May Be Too Generic
TheStreet.com
Fri, 10/21/16 - 11:39 am
Tags:
Novartis, generics, patents, Sandoz
Novartis links up with Cerulean in NDC deal
BioPharma Dive
Thu, 10/20/16 - 09:28 am
Tags:
Novartis, Cerulean, NDCs, drug development, R&D
Earnings guide: A preview of 9 big pharmas in Q3
BioPharma Dive
Wed, 10/19/16 - 11:52 am
Tags:
earnings, Roche, Merck, Eli Lilly, Novartis, GSK, Bristol-Myers Squibb, Sanofi, Pfizer, AstraZeneca
Eli Lilly’s new psoriasis treatment Taltz launches first ads, chasing Novartis’ Cosentyx lead
Fierce Pharma
Wed, 10/12/16 - 11:33 am
Tags:
Eli Lilly, psoriasis, Novartis, Cosentyx, Taltz, drug ads
Novartis-backed Gamida Cell grabs a breakthrough trophy for experimental cell treatment
Endpoints
Tue, 10/11/16 - 09:25 pm
Tags:
Gamida Cell, Novartis, NiCord, bone marrow transplants, breakthrough status
Novartis Targets Breast Cancer Drug Approval to Take on Pfizer
Bloomberg
Sat, 10/8/16 - 03:48 pm
Tags:
Novartis, Pfizer, breast cancer, ribociclib
Novartis to pay $35 million to settle charges of illegally promoting a drug for infants
Stat/Pharmalot
Thu, 10/6/16 - 09:30 am
Tags:
Novartis, Elidel, whistleblower lawsuits, off-label
Novartis’ ongoing global R&D reorganization claims another group with 85 staffers
Endpoints
Tue, 10/4/16 - 10:15 pm
Tags:
Novartis, R&D, layoffs, reorganization
Big Pharma vs Big Pharma in court battles over biosimilar drugs
Yahoo/Reuters
Mon, 10/3/16 - 09:58 am
Tags:
Big Pharma, patents, biosimilars, Novartis, Amgen, Biogen, Sanofi, Merck, Eli Lilly, Pfizer, JNJ
Novartis, Amgen rack up their first PhIII success in a crowded CGRP migraine drug field
Endpoints
Thu, 09/29/16 - 08:23 am
Tags:
Novartis, Amgen, CGRP blockers, migraines, erenumab
Novartis's Zykadia gets positive results, faces Roche pressure
Yahoo/Reuters
Fri, 09/23/16 - 10:07 pm
Tags:
Novartis, Zykadia, Roche, non-small cell lung cancer
Novartis preps Zykadia for a frontline NSCLC pitch, but faces a tough rival in Roche; J&J, GSK hustle RA drug sirukumab to the FDA
Endpoints
Fri, 09/23/16 - 11:47 am
Tags:
Novartis, Zykadia, non-small cell lung cancer, Roche, JNJ, GSK, rheumatoid arthritis, sirukumab
Novartis continues data push for Entresto
BioPharma Dive
Wed, 09/21/16 - 11:01 pm
Tags:
Novartis, Entresto, heart failure
Novartis' Multiple Sclerosis Life Cycle Looks More Assured
Seeking Alpha
Tue, 09/20/16 - 09:48 am
Tags:
Novartis, siponimod, MS, multiple sclerosis
Roche To Topple Novartis As Industry's Biggest Seller
Seeking Alpha
Sun, 09/18/16 - 10:03 am
Tags:
Roche, Novartis, drug sales
Novartis shows a hole card in a high-stakes PhIII poker game for MS drugs
Endpoints
Sat, 09/17/16 - 01:23 pm
Tags:
Novartis, MS, multiple sclerosis, siponimod
Alcon sale? Novartis exec won't rule it out
Fierce Pharma
Sat, 09/17/16 - 01:12 pm
Tags:
Novartis, Alcon, M&A, Joe Jimenez
One Company's Employees Say an Acquisition Was Mishandled
CP Wire
Fri, 09/16/16 - 10:34 am
Tags:
layoffs, M&A, Novartis, Alcon
GlaxoSmithKline Giving a Shot to Its Vaccines Business
Market Realist
Tue, 09/13/16 - 09:09 pm
Tags:
GSK, vaccines, Novartis, M&A, Rotarix, Boostrix, Bexsero, Menveo

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.